Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results 24 February
Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use 21 January
